Advertisement
Salesforce
Salesforce

Most Recent

image: Subglacial Ecosystem

Subglacial Ecosystem

By | August 22, 2014

Samples from an Antarctic lake 800 meters below the ice reveal an abundance of microbial life.

0 Comments

image: Marburg Drug Shows Promise

Marburg Drug Shows Promise

By | August 22, 2014

Monkeys infected with lethal doses of Marburg virus were rescued by an experimental siRNA-based therapeutic, a study shows.

0 Comments

image: How Hummingbirds Taste Nectar

How Hummingbirds Taste Nectar

By | August 21, 2014

Hummingbirds perceive sweetness through a receptor with which other vertebrates taste savory foods. 

0 Comments

image: Viral Demise of an Algal Bloom

Viral Demise of an Algal Bloom

By | August 21, 2014

Marine viruses may be key players in the death of massive algal blooms that emerge in the ocean, a study shows.

0 Comments

image: RNA-based Sex Determination?

RNA-based Sex Determination?

By | August 20, 2014

Researchers find that microRNAs may play a role some of the sexual differences seen in fruit flies.

1 Comment

image: DARPA Challenge to Predict Chikungunya Spread

DARPA Challenge to Predict Chikungunya Spread

By | August 19, 2014

Contest aims to identify models that accurately forecast outbreaks.

0 Comments

image: WHO: Ebola Outbreak Underestimated

WHO: Ebola Outbreak Underestimated

By | August 18, 2014

The World Health Organization says the ongoing Ebola outbreak may be worse than their official numbers show and notes that it’s still considering the use of several experimental therapies.

1 Comment

image: Chikungunya Vaccine Clears Phase 1

Chikungunya Vaccine Clears Phase 1

By | August 18, 2014

Early-stage clinical trial yields promising results. 

0 Comments

image: Week in Review: August 11–15

Week in Review: August 11–15

By | August 15, 2014

Early antibiotics lead to obesity; plants communicate with mRNA; how chikungunya spreads; development of the premature infant gut microbiome; bonobo empathy

0 Comments

image: Biotech Terminates IPO

Biotech Terminates IPO

By | August 15, 2014

The Israeli firm Vascular Biogenics withdrew its initial public offering after six days of trading. 

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
NeuroScientistNews
NeuroScientistNews

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
The Scientist
The Scientist
Advertisement
NeuroScientistNews
NeuroScientistNews
Life Technologies